Displaying 1 to 5 of 5 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Bluebird Bio Inc Developer of an innovative gene therapies for severe genetic disorders |
United States | 1 Mar 2010 | Series B |
|
|
Fate Therapeutics Inc |
United States | 1 Nov 2009 | Series B Initial investment. Round participant. Active |
|
|
GelTex Pharmaceuticals |
United States | 11 Sep 2000 | Acquisition 1,000,000,000 (USD 1,000,000,000) deal size. |
|
|
|
ILEX Oncology Inc |
United States | N/A |
||
|
|
Sirtris Pharmaceuticals Inc |
United States | 1 Apr 2006 | Series C |